pravastatin has been researched along with Esophageal Squamous Cell Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chen, WM; Shia, BC; Wu, SY; Yu, YH | 1 |
| Chen, Y; Li, LB; Tang, DP; Wei, JJ; Zhang, J; Zhuang, ZH | 1 |
2 other study(ies) available for pravastatin and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Pravastatin; Propensity Score; Rosuvastatin Calcium | 2023 |
Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation; Humans; Pravastatin; Simvastatin | 2018 |